Valvular heart disease can be an important finding in patients presenting for noncardiac
surgery. Valvular heart disease and resulting comorbidity, such as heart failure or atrial …

The prevalence of advanced valvular heart disease in the United States currently stands at
2.5% and is expected to increase considerably with the aging of the population. 1 With this …

Valvular heart disease remains a prevalent and challenging condition in healthcare settings,
particularly in thirdworld and developing countries3. Rheumatic heart disease continues to …

BACKGROUND: The beneficial effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG Co-
A) reductase inhibitors (statins) in patients undergoing coronary artery bypass grafting have …

Background: Statin therapy has been thought to improve outcomes in cardiac surgeries. We
aimed to determine the statin effects on the development of postoperative atrial fibrillation …

Valvular heart disease presents as mixed spectrum lesion in healthcare settings in the third-
world and developing countries. Rheumatic heart disease still forms the bulk of the …

OBJECTIVE: The aim of the present study was to assess the influence of preoperative statin
therapy on postoperative mortality in high-risk patients after isolated valve surgery. DESIGN …

BACKGROUND: It is unknown whether patients undergoing valve surgery benefit from
preoperative statin therapy. We examined the effects of statin treatment in a large group of …

Valvular heart disease in a variety of forms is not uncommon, especially among older
patients undergoing noncardiac surgery, and can be associated with increased …

Valvular heart disease contributes to a large burden of morbidity and mortality in the United
States. During the last decade there has been a paradigm shift in the management of valve …